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Abstract
Background: Patients with juvenile dermatomyositis (JDM) often present strong exercise intolerance and muscle
weakness. However, the role of exercise training in this disease has not been investigated.
Purpose: this longitudinal case study reports on the effects of exercise training on a 7-year-old patient with JDM
and on her unaffected monozygotic twin sister, who served as a control.
Methods: Both the patient who was diagnosed with JDM as well as her healthy twin underwent a 16-week
exercise training program comprising aerobic and strengthening exercises. We assessed one repetition-maximum
(1-RM) leg-press and bench-press strength, balance, mobility and muscle function, blood markers of inflammation
and muscle enzymes, aerobic conditioning, and disease activity scores. As a result, the healthy child had an overall
greater absolute strength, muscle function and aerobic conditioning compared to her JDM twin pair at baseline
and after the trial. However, the twins presented comparable relative improvements in 1-RM bench press, 1-RM leg
press, VO2peak, and time-to-exhaustion. The healthy child had greater relative increments in low-back strength and
handgrip, whereas the child with JDM presented a higher relative increase in ventilatory anaerobic threshold
parameters and functional tests. Quality of life, inflammation, muscle damage and disease activity scores remained
unchanged.
Results and Conclusion: this was the first report to describe the training response of a patient with non-active
JDM following an exercise training regimen. The child with JDM exhibited improved strength, muscle function and
aerobic conditioning without presenting an exacerbation of the disease.
Background
Juvenile dermatomyositis (JDM) is a rare, idiopathic and
non-suppurative inflammatory disease that causes proxi-
mal muscle weakness and a variety of cutaneous features
[1]. Current treatment includes corticosteroids fre-
quently in combination with other immunosuppressive
agents such as methotrexate and cyclosporine, or intra-
venous immunoglobulin. Ou rg r o u p[ 1 - 4 ]a n do t h e r s
[5,6] have consistently showed that, despite the improve-
ments in JDM prognosis over the last three decades, a
number of patients may develop irreversible cumulative
damage due to the disease activity or its treatment.
Patients with JDM often present strong exercise intol-
erance [6,7]. Furthermore, muscle waste usually occurs
during periods of disease activity, leading to muscle
weakness [8]. In adults with dermatomyositis and poly-
myositis [9-12] and inclusion body myositis [13,14], phy-
sical training studies have shown improvements in
exercise capacity. Therefore, it would be clinically rele-
vant to investigate the effects of exercise training in
JDM patients.
This longitudinal case study aimed to investigate the
effects of exercise training in a 7-year-old patient with
JDM, with her unaffected monozygotic twin sister ser-
ving as a control. This approach provided a unique
opportunity to evaluate the responsiveness and tolerabil-
ity to exercise in JDM. * Correspondence: clovis.silva@icr.usp.br
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A2 - y e a r - o l dg i r lp r e s e n t i n g muscle weakness, myalgia,
difficulty in walking, and re-current episodes of falls,
fever and progressive weight loss was first examined at
the Pediatric Hospital in 2005. The initial physical eva-
luation revealed some hematomas, malar and nasal
erythema, Gottron’s papules on proximal and distal
interfalangeans, muscle pain on palpation, proximal
muscle weakness (IV - Medical Research Council)a n d
the positive Gower’s sign. Lactic dehydrogenase [LDH]
(563 IU/L, normal range 211-423 IU/L) and aldolase
(12.9 IU/L, normal range 1-7.5 IU/L) were increased.
Additional biochemical investigations revealed neither
systemic inflammation nor increased serum skeletal
muscle enzymes (erythrocyte sedimentation rate [ESR]:
16 mm/h, normal range 0-20 mm/h; C-reactive protein
[CRP]: 2.1 mg/L, normal range 0-5 mg/L; aspartate ami-
notransferase [AST]: 23 U/L, normal range 10-34 U/L;
alanine aminotransferase [ALT]: 13 IU/L, normal range
10-44 IU/L; creatine kinase [CK]: 60 IU/L, normal range
24-204 IU/L; Antinuclear antibody titres (ANA) and
anti-Jo1 were negatives. Esophagogastroduodenoscopy
showed a mild gastroesophageal reflux disease and
radiographies indicated calcinosis in the right calf,
elbows and arms. Echocardiogram, abdominal ultra-
sound and dual energy x-ray absorptiometry (DEXA)
scan revealed no abnormalities. The JDM diagnosis was
made according to Bohan and Peter’sc r i t e r i a[ 1 5 ] ,i . e . ,
the presence of inflammatory infiltrate and perifascicular
atrophy at muscle histopathology and typical electro-
myography abnormalities. Prednisone was promptly
initiated in 2005 (1.5 mg/kg/day) and was progressively
tapered and then discontinued in 2006. Afterwards, the
patient remained in remission without any medication.
According to the parent’s report, the children had
never been engaged in extra-curricular sports or physi-
cal activity programs, even though both of them had
been equally encouraged to participate in physical edu-
cation activities at school. In 2009, the JDM patient (age
7 ;w t :2 3k g ;h t :1 . 1 6m ;V O 2peak: 41.3 mL/Kg/min) was
engaged in a twice-a-week, 16-week combined resistance
and aerobic training program. Her unaffected monozy-
gotic twin sister (wt: 23 kg; ht 1.20 m; VO2peak 42.2 mL/
Kg/min) was submitted to the same program, serving as
a healthy control. Training sessions consisted of a 5-min
treadmill warm-up followed by a 25-min resistance
training (bench-press, leg-press, lat-pulldown, leg-
extension, and seated-row exercises), a 30-min treadmill
aerobic training, and 5-min stretching exercises. Resis-
tance training comprised four sets of 8-12 repetitions-
maximum (RM; defined as the maximal load for which
a certain number of repetitions can be performed). Dur-
ing the first week, a reduced exercise volume regimen
(two sets of 15-20 RM) was adopted. Aerobic training
intensity was monitored by a heart-rate (HR) monitor
(70% of the HR correspondent to VO2peak). All sessions
were performed in an intrahospital gymnasium and
monitored by two fitness professionals. This study was
approved by the local Ethical Committee and informed
written consent was given by the subjects’ parents.
Prior to and after the 16-week program, we assessed
dynamic strength (1-RM for leg press and bench press
[16]) and isometric strength (handgrip for the dominant
arm and lower back extension). Muscle function was
evaluated through timed up-and-go and timed-stands
tests [17]. To avoid learning effects, the twins underwent
six familiarization sessions, at least 72 h apart, for all
strength and functional tests. The coefficients of varia-
tion (CV) for these tests were ≤0.5%. The children were
also submitted to cardiopulmonary tests to determine
the VO2peak, ventilatory anaerobic threshold (VAT),
exercise time at VAT (tVAT) and time-to-exhaustion,
according to a previous description [18]. The physical
function was evaluated by the Childhood Health Assess-
ment Questionnaire (CHAQ) [19]. JDM scores included
Manual Muscle Test (MMT) [20], Childhood Muscle
Assessment Scale (CMAS) [21], Visual Analogue Scale
(VAS) and Physician Global Assessment of Disease
Activity (PGA) and Parents/Patient Global Assessment
of Disease Activity (PaGA) [22]. Laboratory parameters
of inflammation and serum skeletal muscle enzymes
were also assessed at baseline and 48 h after the last
training session.
Except for 1-RM bench press and VO2peak, the healthy
child tended to present greater absolute strength, func-
tion and aerobic conditioning than her twin pair at
baseline and after the trial. However, relative improve-
ments (i.e., the percent difference between pre- and
post-training) in 1-RM bench press, 1-RM leg press,
VO2peak, and time-to-exhaustion were similar between
the twins. The healthy child presented greater relative
increments in lower-back and handgrip strength,
whereas the JDM patient presented a higher increase in
VAT, tVAT, timed-stands test, and timed-up-and-go
test (Table 1).
There was no evidence of exercise-induced exacerba-
tion of inflammation or disease flare. Quality of life
scores were also virtually unaltered (Table 2). No clini-
cal evidence of excessive exhaustion, pain, osteoarticular
injury, muscle soreness, or any other adverse event was
noticed.
Discussion
JDM is a significant illness that leads to exercise intoler-
ance, disability, and physical inactivity. Since the intro-
duction of new therapies, the attention of outcome
measures has shifted from mortality towards morbidity,
functional ability, and exercise capacity [1-5,7]. However,
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in JDM. In this context, we reported for the first time
the benefits of an exercise training program on physical
capacity in a child with JDM. The results obtained were
compared with those from her monozygotic unaffected
sister, allowing us to assume that the JDM patient is
effectively responsive to exercise training.
Notwithstanding the long-term period without dis-
ease flare, the JDM child presented overall slightly
impaired physical capacity as compared with her
healthy peer, corroborating previous observations from
Takken et al. [7] who found reduced physical capacity
in children with inactive disease versus normative
healthy values. These findings led the authors to spec-
ulate that some exercise parameters lack the respon-
siveness to improving after an active period of the
disease. According to Takken et al. [7], there are sev-
eral pathophysiologic explanations for the significant
impairment in exercise capacity in JDM patients: the
increased concentration of intramuscular cytokines,
the systemic inflammation process, the inflammation
of muscular capillaries, the lack of physical activity,
the impaired muscle oxidative capacity, and the effect
of glucocorticoid treatment on body mass gain and
protein breakdown [7,23]. Interestingly, it has been
consistently showed that exercise training counteracts
several of these deleterious effects across a variety of
diseases, reducing systemic inflammation and vascular
reactivity, attenuating glucocorticoid-induced adverse
effects, increasing muscle mass and neuromuscular
function, reducing fat accumulation, and improving
oxidative capacity and neovascularization [24,25].
Because of its vast spectrum of action, exercise has
been considered a promising therapeutic tool in JDM
[26]. Supporting this concept, the current exercise
intervention yielded remarkable improvements in aero-
b i cc a p a c i t y( e . g . ,i n c r e m e n to f1 6 6 . 7 %i nt h ee x e r c i s e
time at VAT), which is knowingly impaired in JDM
patients [7,23].
Historically, exercises and muscle strengthening have
often been avoided in JDM. It was believed that exercise
may cause muscle fiber damage and inflammation in
JDM [24]. However, recent evidence suggests that a sin-
gle exercise bout for children with non-active JDM does
not increase muscle inflammation [27]. Our clinical and
laboratory findings further support this concept, sug-
gesting that a controlled exercise program may be toler-
able in JDM patients. However, our patient was in
remission for approximately three years, thus caution
should be exercised in extrapolating these results to
patients with active disease.
Conclusions
This was the first report to describe the training
response of a patient with non-active JDM following an
exercise training regimen. The child exhibited improved
strength, muscle function and aerobic conditioning
without experiencing exacerbation of the disease. The
clinical observations from this account suggest that this
promising intervention merits additional controlled
studies.
Table 1 Effetcs of a 16-week exercise program on
physical capacity in a 7-year-old patient with juvenile
dermatomyositis (JDM) patient and in her unaffected
monozygotic twin sister
Healthy twin JDM twin
Variable Pre Post Δ (%) Pre Post Δ (%)
1RM bench press (Kg) 13.0 17.0 30.8 13.0 17.0 30.8
1RM leg press (Kg) 25.0 30.0 20.0 13.0 15.0 15.4
Handgrip (Kg) 7.0 9.0 28.6 4.0 5.5 37.5
Low-back strength (Kg) 40.0 47.0 17.5 35.0 40 12.5
Timed-stands test (rep) 18.0 19.0 5.5 15.0 18.0 12.0
Timed-up-and-go test (s) 6.6 6.1 -7.6 8.8 6.2 -29.5
VO2peak (mL/Kg/min) 42.2 44.7 6.0 41.3 43.6 5.6
Exercise time at VAT (min) 6.0 10.3 71.7 3.0 8.0 166.7
VAT (% VO2peak) 80.1 80.5 0.5 57.5 67.8 17.9
VAT (mph) 3.5 3.5 0.0 2.5 3.5 40.0
Time-to-exhaustion (min) 13.3 15.3 15.0 12.3 14.3 16.3
Abbreviations: RM = maximum repetition; VO2peak = peak oxygen
consumption; VAT = ventilatory anaerobic threshold; Δ = Delta.
Table 2 Effects of a 16-week exercise program on clinical
and laboratorial parameters related to inflammation,
muscle damage, pain, disease activity, and quality of life
in a 7-year-old patient with juvenile dermatomyositis
(JDM) and in her unaffected monozygotic twin sister
Healthy twin JDM twin
Variable Pre Post Pre Post
CMAS 49 49 46 46
MMT 80 80 80 80
CHAQ 0 0 0 0
VAS (Physician’s scale) 0 0 0 0
VAS (Parents’ scale) 0 0 0 0
PGA 0 0 0 0
PaGA 0 0 0 0
CK (IU/L) 152 201 155 218
LDH (IU/L) 213 166 171 183
Aldolase (IU/L) 6 6 7 7
ESR (mm/hr) 12 15 20 20
C-reactive protein (mg/L) 0.32 0.79 1.73 0.70
Abbreviations: CMAS = Childhood Muscle Assessment Scale; MMT = Manual
Muscle Test; CHAQ = Childhood Health Assessment Questionnaire; VAS =
Visual Analogic Score; PGA = Physician Global Assessment of Disease Activity;
PaGA = Parents/Patient Global Assessment of Disease Activity; CK = Creatine
kinase; LDH = Lactate Dehydrogenase; ESR = Erythrocyte Sedimentation Rate.
Normal range for CK, LDH, aldolase, ESR and C-reactive protein are 24-192 IU/
L, 141-237 IU/L, 1-7.4 IU/L, 0-20 mm/1
st hr, 0-5 mg/L, respectively. Score range
for CMAS, MMT, CHAQ, PGA and PaGA are 0-52, 0-80, 0-3, 0-10, 0-10,
respectively.
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